How macro-level sampling affects micro-level arguments: A rejoinder to Steven Casper

Socio-Economic Review

Volumn 8, Issue 2, 2010, Pages 333-339

  Herrmann, Andrea M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Firm strategy; Innovation; Institutional political economy; Methodology

Indexed keywords

EID: 77951792840     PISSN: 14751461     EISSN: 1475147X     Source Type: Journal    
DOI: 10.1093/ser/mwp036     Document Type: Article

References (13)

1. Casper, S. (2000) 'Institutional Adaptiveness, Technology Policy, and the Diffusion of New Business Models: The Case of German Biotechnology', Organization Studies, 21, 887-914.
2. Casper, S. (2007) Creating Silicon Valley in Europe: Public Policy towards New Technology Industries, Oxford, Oxford University Press.
3. Casper, S. (2009) 'Can New Technology Firms Succeed in CoordinatedMarket Economies? A Response to Herrmann and Lange', Socio-Economic Review, 7, 209-215.
4. Casper, S. and Matraves, C. (2003) 'Institutional Frameworks and Innovation in the German and UK Pharmaceutical Industry', Research Policy, 32, 1865-1879.
5. Casper, S. and Whitley, R. (2004) 'Managing Competences in Entrepreneurial Technology Firms: a Comparative Institutional Analysis of Germany, Sweden, and the UK', Research Policy, 33, 89-106.
6. Casper, S., Lehrer, M. and Soskice, D. (1999) 'Can High-Technology Industries Prosper in Germany? Institutional Frameworks and the Evolution of the German Software and Biotechnology Industries', Industry and Innovation, 6, 5-24.
7. Herrmann, A. M. (2008a) 'Rethinking the Link between Labour Market Flexibility and Corporate Competitiveness: a Critique of the Institutionalist Literature', Socio-Economic Review, 6, 637-669.
8. Herrmann, A. M. (2008b) One Political Economy, One Competitive Strategy? Comparing Pharmaceutical Firms in Germany, Italy, and the UK, Oxford, Oxford University Press.
9. Herrmann, A. M. (2008c) 'Contrasting the Resource-based View and Competitiveness Theories: How Pharmaceutical Firms Choose to Compete in Germany, Italy and the UK', Strategic Organization, 6, 343-374.
10. Herrmann, A. M. (2009) 'On the Choice and Success of Competitive Strategies', Competition and Change, 13, 3-28.
11. Lange, K. (2009) 'Institutional Embeddedness and the Strategic Leeway of Actors: The Case of the German Therapeutical Biotech Industry', Socio-Economic Review, 7, 181-207.
12. Robinson,W. S. (1950) 'Ecological Correlations and the Behavior of Individuals', American Sociological Review, 15, 351-357.
13. Utterback, J. M. (1994) Mastering the Dynamics of Innovation - How Companies Can Seize Opportunities in the Face of Technological Change, Boston, MA, Havard Business School Press.